Ken H. Young

27.3k citations

242 papers · 9.3k indexed · 3 hit papers · h-index 52

Impact in

Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research

Papers in

Pathology and Forensic Medicine 155
- Lymphoma Diagnosis and Treatment 152
Genetics 71
- Chronic Lymphocytic Leukemia Research 69

Co-authors: L. Jeffrey Medeiros Zijun Y. Xu‐Monette Chi Young Ok Shaoying Li Yong Li Jianfeng Zhou Mingzhi Zhang Jianyong Li
Journals: Blood (28 papers)The American Journal of Surgical Pathology (12 papers)Oncotarget (11 papers)Journal of Hematology & Oncology (9 papers)Modern Pathology (8 papers)
Partner nations: United States China Denmark

In The Last Decade

Ken H. Young

238 papers receiving 9.1k citations

Hit Papers

align trajectories log scale

Diffuse large B-cell lymphoma 2017 · 407 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 Pathology
2017 Blood
2012 Journal of Clinical Oncology

Peers

Countries citing papers authored by Ken H. Young

Since Specialization

Citations

This map shows the geographic impact of Ken H. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken H. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken H. Young more than expected).

Fields of papers citing papers by Ken H. Young

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken H. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken H. Young. The network helps show where Ken H. Young may publish in the future.

Co-authors

The 25 scholars most cited alongside Ken H. Young, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ken H. Young Line = papers co-authored together Ken H. Young links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Practical microenvironment classification in diffuse large B cell lymphoma using digital pathology Cell Reports Medicine ·Yuqing Wang, Shuo Wang, Hongmei Yi, Ying Qian, Yue Wang, Haimin Xu, Zijun Y. Xu‐Monette, Karolyn Au, Shuang Tian, Yan Dong, Jing Zhao, Di Fu, Rongji Mu, Shu-Ye Wang, Li Wang, Ken H. Young, Pengpeng Xu, Weili Zhao	2025	3
2	Long-Term Results of Ipilimumab Alternating with Lenalidomide in Patients with Relapsed Lymphoma Who Underwent Hematopoietic Cell Transplantation Transplantation and Cellular Therapy ·Joseph Jabbour, Padmanee Sharma, Denái R. Milton, Alison Gulbis, Fadi Haddad, Richard E. Champlin, Ken H. Young, Issa F. Khouri	2025	0
3	Minimal residual disease detection in lymphoma: methods, procedures and clinical significance Frontiers in Immunology ·Sijun Zhang, Xiangyu Wang, Zhen-Zhen Yang, Mengjie Ding, Mingzhi Zhang, Ken H. Young, Xudong Zhang	2024	4
4	Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant Bone Marrow Transplantation ·Taha Al‐Juhaishi, Yingjun Wang, Denái R. Milton, Zijun Y. Xu‐Monette, Elias Jabbour, May Daher, Jin S. Im, Qaiser Bashir, Swaminathan P. Iyer, David Marín, Amanda Olson, Uday Popat, Muzaffar H. Qazilbash, Gabriela Rondón, Alison Gulbis, Richard E. Champlin, Ken H. Young, Issa F. Khouri	2023	3
5	EZH2 expression is associated with inferior overall survival in mantle cell lymphoma Modern Pathology ·Diana Lucía Martínez-Baquero, Ali Sakhdari, Huan Mo, Do H. Kim, Rashmi Kanagal‐Shamanna, Shaoying Li, Ken H. Young, Dennis P. O’Malley, Ahmet Doǧan, Preetesh Jain, Michael Wang, Timothy J. McDonnell, Roberto N. Miranda, Francisco Vega, L. Jeffrey Medeiros, Chi Young Ok	2021	8
6	Vulvar Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma International Journal of Gynecological Pathology ·Daniel C Morse, Katherine E. Park, Vida Chitsazzadeh, Shaoying Li, Ken H. Young, Jillian R. Gunther, Bouthaina S. Dabaja, Madeleine Duvic	2021	2
7	CD19-specific CAR T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1–positive B-Cell Lymphoma Clinical Cancer Research ·Hui Liu, Wen Lei, Chaoting Zhang, Chunmei Yang, Juying Wei, Qunyi Guo, Xiaojun Guo, Zhilu Chen, Ying Lu, Ken H. Young, Zheming Lu, Wenbin Qian	2020	104
8	MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index BMC Cancer ·Hanne Due, Rasmus Froberg Brøndum, Ken H. Young, Martin Bøgsted, Karen Dybkær	2020	11
9	MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis Blood ·Xinfang Yu, Wei Li, Qipan Deng, Haidan Liu, Xu Wang, Hui Hu, Ya Cao, Zijun Y. Xu‐Monette, Ling Li, Mingzhi Zhang, Zhongxin Lu, Ken H. Young, Yong Li	2020	26
10	Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas Clinical Cancer Research ·Lan V. Pham, Shengjian Huang, Hui Zhang, Jun Zhang, Taylor Bell, Shouhao Zhou, Elizabeth Pogue, Zhiyong Ding, Laura Lam, Jason R. Westin, R. Eric Davis, Ken H. Young, L. Jeffrey Medeiros, R. Ford, Krystle Nomie, Leo Yu Zhang, Michael Wang	2018	63
11	MYD88 L265P Mutation in Lymphoid Malignancies Cancer Research ·Xinfang Yu, Wei Li, Qipan Deng, Ling Li, Eric D. Hsi, Ken H. Young, Mingzhi Zhang, Yong Li	2018	81
12	Identification of PTX3 and S100A9 As Serum Diagnostic and Therapeutic Response Biomarkers of NK/T Cell Lymphoma Patients Blood ·Zhi‐Yuan Zhou, Zhaoming Li, Weili Xue, Xudong Zhang, Ken H. Young, Yingjun Wang, Mengyuan Jin, Mingzhi Zhang	2017	2
13	An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCL Blood ·Yun Mai, Jingwei Yu, Boris Bartholdy, Zijun Y. Xu‐Monette, Esther Knapp, Fei Yuan, Hongshan Chen, B. Belinda Ding, Zhihua Yao, Bhaskar C. Das, Yiyu Zou, Ken H. Young, Samir Parekh, B. Hilda Ye	2016	48
14	Successful treatment of aplastic anemia–paroxysmal nocturnal hemoglobinuria associated with eosinophilic fasciitis with matched unrelated donor allogeneic peripheral blood stem cell transplantation Clinical Case Reports ·Koji Sasaki, Uday Popat, Preetesh Jain, Tapan M. Kadia, Krina K. Patel, Keyur P. Patel, Nitin Jain, Koichi Takahashi, Ken H. Young, Roberto N. Miranda, Thein Hlaing Oo, Huifang Lu, Naveen Pemmaraju	2016	2
15	Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 cases Annals of Diagnostic Pathology ·Le Aye, Sanam Loghavi, Ken H. Young, Imran Siddiqi, C. Cameron Yin, Mark J. Routbort, Mei Liang, Keith Eilerman, L. Jeffrey Medeiros, Russell K. Brynes, Carlos Bueso-Ramos	2016	9
16	Tetraspanin CD37 protects against the development of B cell lymphoma Journal of Clinical Investigation ·Charlotte M. de Winde, Sharon Veenbergen, Ken H. Young, Zijun Y. Xu‐Monette, Xiao-Xiao Wang, Yi Xia, Kausar J. Jabbar, Michiel van den Brand, Alie van der Schaaf, Suraya Elfrink, Inge S. van Houdt, Marion J. Gijbels, Fons A. J. van de Loo, Miranda B. Bennink, Konnie M. Hebeda, Patricia J.T.A. Groenen, J. Han van Krieken, Carl G. Figdor, Annemiek B. van Spriel	2016	41
17	Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma Journal of Clinical Pathology ·Emil Frei, Carlo Visco, Zijun Y. Xu‐Monette, S Dirnhofer, Karen Dybkær, Attilio Orazi, Govind Bhagat, Eric D. Hsi, J. Han van Krieken, Maurilio Ponzoni, Ronald S. Go, Miguel Á. Piris, Michael Møller, Ken H. Young, Alexandar Tzankov	2013	19
18	Clonal Evolution in t(14;18)-Positive Follicular Lymphoma, Evidence for Multiple Common Pathways, and Frequent Parallel Clonal Evolution Clinical Cancer Research ·Francesco d’Amore, Eric Y. Chan, Javeed Iqbal, Huimin Geng, Ken H. Young, Xiao Li, Michelle M. Hess, Warren G. Sanger, Lynette M. Smith, Carsten Wiuf, Oskar Hagberg, Kai Fu, Wing C. Chan, Bhavana J. Davé	2008	27
19	Inhibition of the p53 E3 Ligase HDM-2 Induces Apoptosis and DNA Damage–Independent p53 Phosphorylation in Mantle Cell Lymphoma Clinical Cancer Research ·Richard J. Jones, Qing Chen, Peter M. Voorhees, Ken H. Young, Nathalie Bruey-Sédano, Dajun Yang, Robert Z. Orlowski	2008	27
20	Pediatric Primary Bone Lymphoma-Diffuse Large B-Cell Lymphoma: Morphologic and Immunohistochemical Characteristics of 10 Cases American Journal of Clinical Pathology ·X. Zhao, Ken H. Young, Dale Frank, Ami Goradia, Michael Glotzbecker, Wilbur J. Pan, Leslie S. Kersun, Ann Leahey, John P. Dormans, John Choi	2006	3

About Ken H. Young

Ken H. Young is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Immunology and Hematology, having authored 242 papers that have together received 9.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (152 papers), Chronic Lymphocytic Leukemia Research (69 papers), Viral-associated cancers and disorders (45 papers), CAR-T cell therapy research (41 papers), Immune Cell Function and Interaction (33 papers), CNS Lymphoma Diagnosis and Treatment (17 papers), Acute Myeloid Leukemia Research (15 papers) and Cutaneous lymphoproliferative disorders research (15 papers). The work is most often cited by research in Pathology and Forensic Medicine (4.2k citations), Genetics (1.9k citations), Oncology (4.4k citations), Cancer Research (1.5k citations) and Immunology (2.0k citations). Ken H. Young has collaborated with scholars based in United States, China and Denmark. Frequent co-authors include L. Jeffrey Medeiros, Zijun Y. Xu‐Monette, Chi Young Ok, Shaoying Li, Yong Li, Jianfeng Zhou, Mingzhi Zhang, Jianyong Li, Roberto N. Miranda and Ling Li. Their work appears in journals such as Blood, The American Journal of Surgical Pathology, Oncotarget, Journal of Hematology & Oncology and Modern Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact